跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 28 条关于
“Hypochondroplasia”
全部
28
临床试验
12
药物
0
机构
0
资讯
16
9天前
BioMarin's VOXZOGO Hits Primary Endpoint in Phase 3 Hypochondroplasia Trial, Published in NEJM Evidence
去年
BioMarin's VOXZOGO Shows Promising Results in Reducing Tibial Bowing in Children with Achondroplasia
9天前
BridgeBio's Oral Infigratinib Shows Benefits Beyond Growth in Phase 3 PROPEL 3 Achondroplasia Trial
18天前
BioMarin Secures 20% Royalty on Ascendis' Yuviwel in Global Patent Settlement
去年
BioMarin's Voxzogo Demonstrates Sustained Height Gains in Achondroplasia Patients
去年
BridgeBio's Encaleret Achieves Calcium Normalization in 80% of Post-Surgical Hypoparathyroidism Patients
去年
BridgeBio Reports Positive Pipeline Progress and Q3 2024 Financial Results
去年
TYRA-300 Shows Promise in Urothelial Cancer Treatment with Projected $63M Revenue by 2036
2年前
Infigratinib Receives FDA Breakthrough Therapy Designation for Achondroplasia
去年
Voxzogo Demonstrates Sustained Efficacy in Real-World Achondroplasia Treatment
第 1 页,共 2 页
上一页
下一页